I migliori medici per il trattamento di Cancro esofageo - TOP-122 medici

Oltre 900 procedure eseguite – Il Dott. Bülent Karagöz è specializzato nel cancro esofageo presso l'Anadolu Medical Center, con 32 anni di esperienza in oncologia.

• Professore presso la Facoltà di Medicina dell'Università di Istanbul Okan
• Autore di oltre 40 pubblicazioni di ricerca in oncologia
• Specializzato in biologia dei tumori e terapie mirate
• Membro dell'Associazione Turca di Oncologia Medica

Si è classificata terza nell'esame di ammissione all'oncologia medica in Turchia, dimostrando una conoscenza del cancro di altissimo livello. Attualmente esercita presso l'Anadolu Medical Center.

• Specialista certificata in oncologia medica
• Oltre 15 anni di esperienza dal conseguimento della laurea in medicina
• Ha ricoperto il ruolo di responsabile dell'unità di oncologia in un importante ospedale di formazione
• Coinvolta attivamente in sperimentazioni cliniche internazionali per nuovi trattamenti contro il cancro
• Formazione di fellowship presso il Dipartimento di Oncologia Medica dell'Università di Marmara

Ha eseguito oltre 400 interventi chirurgici per tumori pancreatici e gastrici – Il Prof. Peker è specializzato in tumori gastrointestinali complessi presso l'Hisar Hospital Intercontinental.

• Formazione presso la Mayo Clinic in chirurgia epatopancreatobiliare
• Fondatore dell'unità di Chirurgia Epatopancreatobiliare in Turchia
• Esperto in trattamenti sia chirurgici che endoscopici
• Ulteriore focus di ricerca sulla biologia del cancro e sulle cellule staminali

Il Dott. Mustafa Solak è specializzato in tumori gastrointestinali, con una formazione di fellowship presso l'Istituto del Cancro dell'Università di Hacettepe.

• Lavora presso l'Hisar Hospital Intercontinental
• Si occupa di casi complessi di cancro esofageo e altri tumori gastrointestinali
• Formazione presso il MD Anderson Cancer Center dell'Università del Texas
• Professore associato in Oncologia Medica

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

Oltre 12.000 interventi chirurgici laparoscopici eseguiti – Il Dr. Ballesta Lopez è un pioniere nelle tecniche minimamente invasive presso il Centro Médico Teknon.

• Oltre 45 anni di esperienza clinica
• Leader internazionale nella chirurgia pancreatica ed esofagea
• Fondatore e Direttore Medico del Centro Laparoscopico Dr. Ballesta
• Utilizza l'assistenza robotica Da Vinci per la precisione

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Il Prof. Sadi Kerem Okutur ha eseguito oltre 1.100 trattamenti presso l'Ospedale Memorial Bahçelievler, specializzandosi nel cancro esofageo.

• 20 anni di esperienza in oncologia medica
• Autore di oltre 20 articoli e 10 capitoli di libri in oncologia
• Vincitore del Premio per la Ricerca in Oncologia nel 2012
• Membro della Società Europea di Oncologia Medica
• Professore associato con un ampio background accademico

Capo di Gastroenterologia e Oncologia presso l'Academic Hospital Solingen – Il Prof. Pfaffenbach è specializzato in tumori complessi del tratto gastrointestinale.

• Oltre 30 anni in gastroenterologia e medicina interna
• Autore di oltre 130 pubblicazioni sulle malattie digestive
• Specializzato in patologie del fegato e delle vie biliari
• Membro della Società Europea di Gastroenterologia
• Sviluppa diete terapeutiche come parte del trattamento

La Dott.ssa Sharon Pelles è un'oncologa altamente rispettata con contributi significativi nella ricerca clinica, inclusi studi sugli atteggiamenti dei pazienti verso le sperimentazioni cliniche.

• Specializzata in vari trattamenti oncologici, inclusa la chirurgia per il cancro allo stomaco
• Esperta in terapie innovative, come l'immunoterapia e la HIPEC
• Lavora presso il Sourasky Medical Center (Ichilov), noto per gli alti tassi di successo

Il Professor Ofer Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, con decenni di esperienza in casi oncologici complessi.

• Oltre 25 anni di specializzazione in tumori gastrointestinali e toracici
• Membro della facoltà ESMO per sarcoma e oncologia toracica
• Formazione specialistica presso l'Institut Gustave Roussy, Parigi
• Partecipante attivo a collaborazioni internazionali di ricerca sul cancro

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Guida uno dei Centri ad Alto Volume per la chirurgia esofagea più riconosciuti d’Italia – più di 2.000 interventi chirurgici annuali presso il San Raffaele.

• Responsabile del Dipartimento di Chirurgia Gastrointestinale dal 2014
• Specializzato in procedure del tratto digerente superiore sia aperte che minimamente invasive
• Oltre 300 pubblicazioni sulle malattie dell'esofago
• Membro della International Society for Diseases of the Esophagus

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology